Ledger.Open graph →
SEC Form D · filed July 24, 2020

Providence Therapeutics Inc

Offering
$2.2M
Sold
$2.2M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
CALGARY, Alberta, Canada
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (18)

Scott Leary · San Diego, CAExec · DirectorBradley T. Sorenson · Calgary, Alberta, CanadaExec · DirectorKenneth Hughes · Calgary, Alberta, CanadaExecDarlene Haslam · Calgary, Alberta, CanadaExecEric Marcusson · San Francisco, CAExecNatalia Orozco · Toronto, Ontario, CanadaExecKimberlee Nelson · Dallas, TXExecJennifer White · Dallas, TXExecScott Mcmullin · Los Angeles, CAExecScott Robinson · Dallas, TXExec · DirectorNelson Rising · Los Angeles, CAExecJohn B. Collis · Boston, MAExec · DirectorRichard W. Scarinci · Boston, MAExec · DirectorWilliam Graff · Newport Coast, CAExecHaiqing Jiang · Mountain View, CAExec · DirectorAntonella Graziano · Luxembourg, LuxembourgExecElisabetta Graff · Newport Coast, CAExecJay Soon · Long Beach, CAExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗